Barcode Diagnostics Overview

  • Founded
  • 2017
Founded
  • Status
  • Private
  • Employees
  • 7
Employees
  • Latest Deal Type
  • Series A2
  • Latest Deal Amount
  • $1.5M
Latest Deal Amount
  • Investors
  • 6

Barcode Diagnostics General Information

Description

Developer of a medical monitoring device designed to be used for personalized cancer drug screening tests. The company's device screens multiple chemotherapy drugs simultaneously in order to assess the efficacy of the treatment on the tumor within the patient's body, enabling physicians to track the drug efficacy on different cell types within the tumor to facilitate optimal drug selection efficiently.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Devices and Supplies
Drug Discovery
Primary Office
  • Wadi El-Haj Street 13
  • Nazareth Illit 17111
  • Israel
+972 00-000-0000

Barcode Diagnostics Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Barcode Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A2) 13-Oct-2020 $1.5M 00.00 Completed Pre-Clinical Trials
2. Early Stage VC (Series A1) 03-Sep-2019 000 00.00 Completed Startup
1. Seed Round 12-Jun-2017 $800K $800K 00.00 Completed Startup
To view Barcode Diagnostics’s complete valuation and funding history, request access »

Barcode Diagnostics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
A Ordinary 0,000,000 000.00 000.00 00 000.00 00.00
To view Barcode Diagnostics’s complete cap table history, request access »

Barcode Diagnostics Executive Team (3)

Name Title Board Seat Contact Info
Ronen Eavri Ph.D Co-Founder and Chief Executive Officer
Annie Sabbah Ph.D Co-Founder and Chief Technology Officer
Avi Schroeder Ph.D Co-Founder, Scientific Advisory Board Member & Inventor
To view Barcode Diagnostics’s complete executive team members history, request access »

Barcode Diagnostics Board Members (5)

Name Representing Role Since
Aharon Schwartz Ph.D Self Board Member 000 0000
Ei Yamada Ph.D Self Board Member 000 0000
Nili Weitzman Self Board Member 000 0000
Ron Laufer MD Self Board Member 000 0000
Zohar Gendler Self Board Member 000 0000
To view Barcode Diagnostics’s complete board members history, request access »

Barcode Diagnostics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Barcode Diagnostics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
AnGes MG Corporation Minority 000 0000 000000 0
Israel Innovation Authority Government Minority 000 0000 000000 0
Next Generation Technology Venture Capital Minority 000 0000 000000 0
OurCrowd Venture Capital Minority 000 0000 000000 0
Sils Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »